TRX BIOSCIENCES LIMITED

Active Cambridge

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
T

TRX BIOSCIENCES LIMITED

Research and experimental development on biotechnology

Founded 9 May 2019 Active Cambridge, England 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

INFIRST (US HOLDINGS) LIMITED 9 May 2019 — 19 Mar 2021
Accounts Submitted 2 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 8 May 2025 Next due 22 May 2026 23 days remaining
Net assets £316K £52K 2024 year on year
Total assets £386K £41K 2024 year on year
Total Liabilities £71K £12K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

280 Babraham Research Campus Cambridge CB22 3AT England

Website

www.example.com

Full company profile for TRX BIOSCIENCES LIMITED (11986839), an active life sciences and medical technology company based in Cambridge, England. Incorporated 9 May 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

N/A

Net Assets

£315.79k

Decreased by £52.34k (-14%)

Total Liabilities

£70.64k

Increased by £11.70k (+20%)

Turnover

N/A

Employees

3

Debt Ratio

18%

Increased by 4 (+29%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 62,532 Shares £500k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Jan 202452,632£500k£9.5
13 May 20229,900£0.99£0

Officers

Officers

1 active 2 resigned
Status
Dan GoodingDirectorEnglishUnited Kingdom5213 May 2022Active

Shareholders

Shareholders (11)

Biocopea Limited
56.1%
Cedar Investments Limited
25.1%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 9 May 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

PEPTCELL LIMITED united kingdom
BIOCOPEA LIMITED united kingdom
TRX BIOSCIENCES LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Feb 2026AddressChange Registered Office Address Company With Date Old Address New Address
16 Oct 2025OfficersTermination of Dan Gooding as director on 10 Oct 2025
19 Jun 2025AddressChange Registered Office Address Company With Date Old Address New Address
2 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
8 May 2025Confirmation StatementConfirmation statement made on 8 May 2025 with no updates
18 Feb 2026 Address

Change Registered Office Address Company With Date Old Address New Address

16 Oct 2025 Officers

Termination of Dan Gooding as director on 10 Oct 2025

19 Jun 2025 Address

Change Registered Office Address Company With Date Old Address New Address

2 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

8 May 2025 Confirmation Statement

Confirmation statement made on 8 May 2025 with no updates

Recent Activity

Latest Activity

Change Registered Office Address Company With Date Old Address New Address

2 months ago on 18 Feb 2026

Termination of Dan Gooding as director on 10 Oct 2025

6 months ago on 16 Oct 2025

Change Registered Office Address Company With Date Old Address New Address

10 months ago on 19 Jun 2025

Annual accounts made up to 31 Dec 2024

11 months ago on 2 Jun 2025

Confirmation statement made on 8 May 2025 with no updates

11 months ago on 8 May 2025